TrialBMC infectious diseases2019

Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection.

Janneke Evelyne Stalenhoef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.